1. Home
  2. News & Events
  3. FDA Meetings, Conferences and Workshops
  4. Public Calendar - Meetings With FDA Officials
  5. Public Calendar: August 31 - September 6, 2025
  1. Public Calendar - Meetings With FDA Officials

Public Calendar: August 31 - September 6, 2025

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Martin A. Makary, M.D., M.P.H., Commissioner for Food and Drugs

Event Date: 09/03/2025
Location: Washington, DC
Subject: Healthy Foods, Accelerating Cures, and Biomedical Research
FDA Participant/Group: BRIAN FAHEY; 
Non FDA Participant/Group: Representative Kathryn 'Kat' Cammack (R-FL)

Event Date: 09/03/2025
Location: Washington, DC
Subject: Rare Disease Drug Development
FDA Participant/Group: BRIAN FAHEY; 
Non FDA Participant/Group: Representative Gus Bilirakis (R-FL)

Event Date: 09/03/2025
Location: Washington, DC
Subject: Wearables and Issues of Mutual Interest
FDA Participant/Group: BRIAN FAHEY; 
Non FDA Participant/Group: Representative Troy Balderson (R-OH)

Event Date: 09/04/2025
Location: North Bethesda, MD
Subject: Bio Innovation Conference 2025; Speaker: Fireside Chat
FDA Participant/Group: SANJULA JAIN; 
Non FDA Participant/Group: Industry, academia, government, media, and other registered attendees

Event Date: 09/05/2025
Location: Washington, DC
Subject: Innovation and Manufacturing
FDA Participant/Group: MICHELLE TARVER; 
Non FDA Participant/Group: Bill Raines, Donald Abbey, Jake Leach, Neeta Sharma (Dexcom);

Official Name: Sara Brenner, M.D., M.P.H., Principal Deputy Commissioner for Food and Drugs

No Significant Event

Official Name: Sean R. Keveney, Chief Counsel

No Significant Event

Official Name: Grace Graham, Deputy Commissioner for Policy, Legislation, and International Affairs

Event Date: 09/02/2025
Location: Virtual
Subject: Hemp
FDA Participant/Group: DANIEL HATTIS; BRIAN FAHEY; NORMAN BIRENBAUM; 
Non FDA Participant/Group: Lindsay Morris, Morgan Orem (Congressional staffer);

Event Date: 09/04/2025
Location: Virtual
Subject: Clinical Trials
FDA Participant/Group: KARIM MIKHAIL; BRIAN FAHEY; SEMA HASHEMI; MARK ABDOO; RAVI BHARWANI; TRACY HOEG; HELEN CHUNG; 
Non FDA Participant/Group: Iga Policinska, Kaye Robertson, Tahli Fenner, Tessa Sherry (Australian Government);

Event Date: 09/04/2025
Location: Virtual
Subject: Rare Disease Medicine Briefing
FDA Participant/Group: KAITLYN WERLEY; BRIAN FAHEY; 
Non FDA Participant/Group: Representative Andrew Clyde (R- GA), Representative Buddy Carter (R-GA), Lucy McBath (Congressional staffer)

Official Name: Kyle Diamantas, J.D., Deputy Commissioner for Human Foods

Event Date: 09/02/2025
Location: College Park, MD
Subject: Human Foods Program Issues of Mutual Interest
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: FDA Foods Coalition representatives

Event Date: 09/03/2025
Location: Washington, DC
Subject: Washington Health Innovation Council Meeting; Speaker: Fireside Chat - Human Foods Program Priorities
FDA Participant/Group: SANJULA JAIN; 
Non FDA Participant/Group: Industry, academia, government, media, and other stakeholders

Event Date: 09/04/2025
Location: Washington, DC
Subject: Seafood Issues of Mutual Interest
FDA Participant/Group: CONRAD CHOINIERE; DONALD PRATER; 
Non FDA Participant/Group: Lisa Wallenda Picard, Lisa Weddig (National Fisheries Institute); Joel Roberson (Holland & Knight);

Official Name: Barclay Butler, Ph.D., Deputy Commissioner for Operations

No Significant Event

Official Name: Lowell Zeta, J.D., Deputy Commissioner for Strategic Initiatives

No Significant Event

Official Name: Elizabeth Miller, Pharm.D., Acting Associate Commissioner for Inspections and Investigations

No Significant Event

Official Name: Vinayak Prasad, M.D., M.P.H., Director, Center for Biologics and Research

Event Date: 09/03/2025
Location: Virtual
Subject: Duke Margolis Institute for Health Policy Workshop, On the RISE: Controls in Rare Disease Clinical Trials for Small and Diminishing Populations; Speaker: Opening Remarks
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Industry, academia, government, media, and other stakeholders

Official Name: Michelle Tarver, M.D., Ph.D., Director, Center for Devices and Radiological Health

No Significant Event

Official Name: George F. Tidmarsh, M.D., Ph.D., Director, Center for Drug Evaluation and Research

Event Date: 09/03/2025
Location: Virtual
Subject: Duke Margolis Institute for Health Policy Workshop, On the RISE: Controls in Rare Disease Clinical Trials for Small and Diminishing Populations; Speaker: Opening Remarks
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, academia, government, media, and other stakeholders

Event Date: 09/04/2025
Location: Silver Spring, MD
Subject: Over the Counter (OTC) Naloxone Injector
FDA Participant/Group: N/A
Non FDA Participant/Group: Michael Wells, Theresa Matkovits (Kaleo);

Official Name: Bret Koplow, Ph.D., J.D., Acting Director, Center for Tobacco Products

No Significant Event

Official Name: Timothy Schell, Ph.D., Acting Director, Center for Veterinary Medicine

No Significant Event

Back to Top